Authors

1. Angelbeck, Judy H. PhD
2. Ortolano, Girolamo A. PhD

Abstract

This article discusses the evidence for the generally accepted uses of leukocyte-reduced blood and the controversy over leukocyte reduction and transfusion-related immunomodulation. A perspective is provided on the continued need for leukocyte reduction on the part of all patients in the United States.